Burning Rock Biotech Limited American Depositary Shares (BNR) Stock Price

BNRStock

$9.80+4.67%52W

Market Cap$103.35M

P/E—

PEG Ratio—

Div yield—

Beta1.50

BNR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-76.32%

Price vs S&P 500 (4W)9.24%

VGM Score40.23

Book Value / Share (Quarterly)$0.71

P/TBV (Annual)2.79x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-1.42%

Cash Flow / Share (Quarterly)$-0.05

Price vs S&P 500 (YTD)-60.54%

Gross Margin (TTM)74.55%

Net Profit Margin (TTM)-11.53%

EPS (TTM)$-0.08

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-0.08

Revenue Growth (5Y)4.65%

EPS (Annual)$-0.08

ROI (Annual)-10.30%

Gross Margin (Annual)74.67%

Net Profit Margin (5Y Avg)-105.68%

Cash / Share (Quarterly)$0.62

Revenue Growth QoQ (YoY)-18.89%

ROA (Last FY)-6.75%

Revenue Growth TTM (YoY)-1.69%

EBITD / Share (TTM)$-0.08

ROE (5Y Avg)-56.42%

Operating Margin (TTM)-11.37%

Cash Flow / Share (Annual)$-0.05

P/B Ratio1.34x

P/B Ratio (Quarterly)2.26x

Net Income / Employee (Annual)$-12,320

EV / Revenue (TTM)0.48x

Net Interest Coverage (TTM)-10.37x

ROA (TTM)-7.31%

EPS Incl Extra (Annual)$-0.08

Current Ratio (Annual)2.99x

Quick Ratio (Quarterly)2.72x

3-Month Avg Trading Volume0.02M

52-Week Price Return4.67%

Revenue / Employee (TTM)$114,487

Tangible BV / Share (Quarterly)$0.71

P/S Ratio (Annual)1.28x

Asset Turnover (Annual)0.66x

52-Week High$6.19

Operating Margin (5Y Avg)-107.01%

EPS Excl Extra (Annual)$-0.08

CapEx CAGR (5Y)-41.94%

Tangible BV CAGR (5Y)-26.04%

26-Week Price Return-65.08%

Quick Ratio (Annual)2.68x

13-Week Price Return-38.20%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.05x

Enterprise Value$36.75M

Revenue / Share Growth (5Y)-39.50%

Asset Turnover (TTM)0.63x

Book Value / Share Growth (5Y)-26.45%

Revenue / Employee (Annual)$120,068

Inventory Turnover (Annual)2.29x

Pretax Margin (Annual)-9.97%

Cash / Share (Annual)$0.66

3-Month Return Std Dev107.83%

Gross Margin (5Y Avg)70.34%

Net Income / Employee (TTM)$-13,196

ROE (Last FY)-10.34%

Net Interest Coverage (Annual)-9.73x

EPS Basic Excl Extra (Annual)$-0.08

P/FCF (TTM)17.54x

Receivables Turnover (TTM)2.91x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.08

Receivables Turnover (Annual)3.10x

ROI (TTM)-10.92%

P/S Ratio (TTM)1.34x

Pretax Margin (5Y Avg)-105.20%

Revenue / Share (Annual)$0.75

Tangible BV / Share (Annual)$0.74

Price vs S&P 500 (52W)-13.65%

Year-to-Date Return-48.78%

5-Day Price Return10.85%

EPS Normalized (Annual)$-0.08

ROA (5Y Avg)-40.98%

Net Profit Margin (Annual)-10.26%

Month-to-Date Return15.96%

EBITD / Share (Annual)$-0.05

Operating Margin (Annual)-10.16%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-56.40%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.08

P/TBV (Quarterly)2.26x

P/B Ratio (Annual)2.79x

Inventory Turnover (TTM)2.19x

Pretax Margin (TTM)-11.23%

Book Value / Share (Annual)$0.74

Price vs S&P 500 (13W)-41.00%

Beta1.50x

Revenue / Share (TTM)$0.73

ROE (TTM)-10.96%

52-Week Low$1.01

vGradeB

gGradeF

mGradeD

vgmGradeC

BNR Earnings Surprise History

Q2 22-3.71est. -2.75

Q3 22-3.46est. -2.79

Q4 22-3.13est. -2.82

Q1 23-2.69est. -2.06

BNR Analyst Recommendations

Oct 2023

Nov 2023

Dec 2023

Jan 2024

4.00

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$9.80
NTRANatera, Inc. Common Stock	F	A	A	$336.71
LHLabcorp Holdings Inc.	C	D	B	$337.68
DGXQuest Diagnostics Inc.	C	D	B	$244.51
GHGuardant Health, Inc. Common Stock	F	A	A	$164.92
CAICaris Life Sciences, Inc. Common Stock	F	A	B	$28.01
RDNTRadNet, Inc. Common Stock	D	C	C	$76.86
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	$100.08
CELCCelcuity Inc. Common Stock	—	—	D	$92.27
GRALGRAIL, Inc. Common Stock	D	A	B	$82.54
VCYTVeracyte, Inc.	D	A	C	$44.04
CDNACareDx, Inc.	D	B	A	$50.80
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.25
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.27
FRNMFreenome, Inc. Common stock	—	F	A	$13.99
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	B	$12.07
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$35.00
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.95
YDESYD Bio Limited Ordinary Shares	—	—	D	$4.68
BDSXBiodesix, Inc. Common Stock	D	B	A	$28.07
XGNExagen Inc. Common Stock	D	B	B	$7.60
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
SERASera Prognostics, Inc. Class A Common Stock	D	D	C	$2.18
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.79
ADVBAdvanced Biomed Inc. Common Stock	A	—	B	$9.18
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	D	$2.49
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	D	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.36

About Burning Rock Biotech Limited American Depositary Shares

Burning Rock Biotech develops NGS-based cancer diagnostics platforms that help oncologists select optimal therapies for patients. The company operates through two revenue-generating channels: a central laboratory model serving smaller hospitals and an in-hospital model for larger medical centers, with the central laboratory business generating the majority of revenues. Its product portfolio includes Pan-HEME, OncoScreen-WES, brPROPHET, and OncoScreen Plus, supplemented by pharma research and development services.